Literature DB >> 25573045

Panel sequencing melanomas.

Klaus G Griewank1, Dirk Schadendorf2.   

Abstract

Sequencing samples of melanoma for targetable mutations has become a standard of care for metastatic disease. In this issue, Siroy et al. demonstrate how clinical genetic analysis is moving from a single-gene Sanger-sequencing approach to targeted next-generation sequencing. They present data on a large cohort of patients with advanced melanoma, and their data support previous findings and also present novel aspects of melanoma genetics.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25573045     DOI： 10.1038/jid.2014.420

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


  10 in total

1.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

2.  A landscape of driver mutations in melanoma.

Authors:  Eran Hodis; Ian R Watson; Gregory V Kryukov; Stefan T Arold; Marcin Imielinski; Jean-Philippe Theurillat; Elizabeth Nickerson; Daniel Auclair; Liren Li; Chelsea Place; Daniel Dicara; Alex H Ramos; Michael S Lawrence; Kristian Cibulskis; Andrey Sivachenko; Douglas Voet; Gordon Saksena; Nicolas Stransky; Robert C Onofrio; Wendy Winckler; Kristin Ardlie; Nikhil Wagle; Jennifer Wargo; Kelly Chong; Donald L Morton; Katherine Stemke-Hale; Guo Chen; Michael Noble; Matthew Meyerson; John E Ladbury; Michael A Davies; Jeffrey E Gershenwald; Stephan N Wagner; Dave S B Hoon; Dirk Schadendorf; Eric S Lander; Stacey B Gabriel; Gad Getz; Levi A Garraway; Lynda Chin
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

3.  Mutations in GNA11 in uveal melanoma.

Authors:  Catherine D Van Raamsdonk; Klaus G Griewank; Michelle B Crosby; Maria C Garrido; Swapna Vemula; Thomas Wiesner; Anna C Obenauf; Werner Wackernagel; Gary Green; Nancy Bouvier; M Mert Sozen; Gail Baimukanova; Ritu Roy; Adriana Heguy; Igor Dolgalev; Raya Khanin; Klaus Busam; Michael R Speicher; Joan O'Brien; Boris C Bastian
Journal:  N Engl J Med       Date:  2010-11-17       Impact factor: 91.245

4.  Mutation and expression of the p53 gene in human malignant melanoma.

Authors:  A P Albino; M J Vidal; N S McNutt; C R Shea; V G Prieto; D M Nanus; J M Palmer; N K Hayward
Journal:  Melanoma Res       Date:  1994-02       Impact factor: 3.599

5.  TERT promoter mutations in familial and sporadic melanoma.

Authors:  Susanne Horn; Adina Figl; P Sivaramakrishna Rachakonda; Christine Fischer; Antje Sucker; Andreas Gast; Stephanie Kadel; Iris Moll; Eduardo Nagore; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

6.  Highly recurrent TERT promoter mutations in human melanoma.

Authors:  Franklin W Huang; Eran Hodis; Mary Jue Xu; Gregory V Kryukov; Lynda Chin; Levi A Garraway
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

7.  TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.

Authors:  Klaus G Griewank; Rajmohan Murali; Joan Anton Puig-Butille; Bastian Schilling; Elisabeth Livingstone; Miriam Potrony; Cristina Carrera; Tobias Schimming; Inga Möller; Marion Schwamborn; Antje Sucker; Uwe Hillen; Celia Badenas; Josep Malvehy; Lisa Zimmer; André Scherag; Susana Puig; Dirk Schadendorf
Journal:  J Natl Cancer Inst       Date:  2014-09-13       Impact factor: 13.506

8.  Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.

Authors:  Alan E Siroy; Genevieve M Boland; Denái R Milton; Jason Roszik; Silva Frankian; Jared Malke; Lauren Haydu; Victor G Prieto; Michael Tetzlaff; Doina Ivan; Wei-Lien Wang; Carlos Torres-Cabala; Jonathan Curry; Sinchita Roy-Chowdhuri; Russell Broaddus; Asif Rashid; John Stewart; Jeffrey E Gershenwald; Rodabe N Amaria; Sapna P Patel; Nicholas E Papadopoulos; Agop Bedikian; Wen-Jen Hwu; Patrick Hwu; Adi Diab; Scott E Woodman; Kenneth D Aldape; Rajyalakshmi Luthra; Keyur P Patel; Kenna R Shaw; Gordon B Mills; John Mendelsohn; Funda Meric-Bernstam; Kevin B Kim; Mark J Routbort; Alexander J Lazar; Michael A Davies
Journal:  J Invest Dermatol       Date:  2014-08-22       Impact factor: 8.551

9.  Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.

Authors:  Michael Krauthammer; Yong Kong; Byung Hak Ha; Perry Evans; Antonella Bacchiocchi; James P McCusker; Elaine Cheng; Matthew J Davis; Gerald Goh; Murim Choi; Stephan Ariyan; Deepak Narayan; Ken Dutton-Regester; Ana Capatana; Edna C Holman; Marcus Bosenberg; Mario Sznol; Harriet M Kluger; Douglas E Brash; David F Stern; Miguel A Materin; Roger S Lo; Shrikant Mane; Shuangge Ma; Kenneth K Kidd; Nicholas K Hayward; Richard P Lifton; Joseph Schlessinger; Titus J Boggon; Ruth Halaban
Journal:  Nat Genet       Date:  2012-07-29       Impact factor: 38.330

10.  Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53.

Authors:  Amaya Viros; Berta Sanchez-Laorden; Malin Pedersen; Simon J Furney; Joel Rae; Kate Hogan; Sarah Ejiama; Maria Romina Girotti; Martin Cook; Nathalie Dhomen; Richard Marais
Journal:  Nature       Date:  2014-06-11       Impact factor: 49.962
  10 in total
  1 in total

1.  Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.

Authors:  Blanca de Unamuno Bustos; Rosa Murria Estal; Gema Pérez Simó; Inmaculada de Juan Jimenez; Begoña Escutia Muñoz; Mercedes Rodríguez Serna; Victor Alegre de Miquel; Margarita Llavador Ros; Rosa Ballester Sánchez; Eduardo Nagore Enguídanos; Sarai Palanca Suela; Rafael Botella Estrada
Journal:  Sci Rep       Date:  2017-03-29       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.